Bluejay Diagnostics Financials - Benzinga

Bluejay Diagnostics Inc

BJDXNASDAQ

Trade with Public

Trade with Public

$0.9494

-0.0107-1.12%

Last update: Aug 20, 10:29 AM

Earnings: Q2 2026 Earnings were released on Thu Aug 13th, before the market open

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

Bluejay Diagnostics Financials

Bluejay Diagnostics (BJDX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.

Benzinga Newsdesk

PRO
Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.95) per share. This is a 85.53 percent increase over losses of $(13.48) per share from the same period last year.

Benzinga Newsdesk

PRO
Bluejay Diagnostics Q2 EPS $(1.41) Up From $(256.16) YoY

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.41) per share. This is a 99.45 percent increase over losses of $(256.16) per share from the same period last year.

Benzinga Newsdesk

PRO
Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings

Avi Kapoor

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

Avi Kapoor